Atlas Venture Life Science Advisors as of March 31, 2025
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 13 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 25.7 | $134M | 4.9M | 27.37 | |
| Disc Medicine Common Stock (IRON) | 22.7 | $118M | 2.4M | 49.64 | |
| Dyne Therapeutics Common Stock (DYN) | 18.3 | $96M | 9.1M | 10.46 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 9.8 | $51M | 6.4M | 7.93 | |
| Sionna Therapeutics Common Stock (SION) | 7.4 | $39M | 3.7M | 10.46 | |
| Third Harmonic Bio Common Stock (THRD) | 6.9 | $36M | 10M | 3.47 | |
| Korro Bio Common Stock (KRRO) | 3.8 | $20M | 1.1M | 17.41 | |
| Vigil Neuroscience Common Stock (VIGL) | 2.0 | $10M | 5.8M | 1.78 | |
| Ikena Oncology Common Stock (IKNA) | 1.2 | $6.4M | 5.0M | 1.28 | |
| Aerovate Therapeutics Common Stock (AVTE) | 0.9 | $4.5M | 1.8M | 2.51 | |
| Q32 Bio Common Stock (QTTB) | 0.7 | $3.5M | 2.1M | 1.65 | |
| Generation Bio Common Stock | 0.6 | $3.4M | 8.3M | 0.41 | |
| Spero Therapeutics Common Stock (SPRO) | 0.0 | $220k | 305k | 0.72 |
